GRINDEKS
Grindeks is a vertically integrated pharmaceutical company with a history from 1946. Its main fields of action are research, development, manufacturing, and sales of original products, generics, and active pharmaceutical ingredients. The company offers heart and cardiovascular, CNS, and anti-cancer medication therapeutic groups.
GRINDEKS
Industry:
Health Care Manufacturing Medical Pharmaceutical
Founded:
1946-01-01
Address:
Riga, Riga, Latvia
Country:
Latvia
Website Url:
http://www.grindeks.eu
Total Employee:
1001+
Status:
Active
Contact:
+371 67083500
Email Addresses:
[email protected]
Technology used in webpage:
Google Maps Pound Sterling Nginx 1.14 10 To 14 CcTLD Redirects
Similar Organizations
AMCo
AMCo is a rapidly-growing international pharmaceutical company.
Brita Trade
Brita Trade is a specialists in leaded glass processing company.
Cilag
Cilag AG is an international operating company integrated in the Janssen Pharmaceutical Companies of Johnson & Johnson.
Doc Generici
A Milan, Italy-based generic pharmaceutical company
Swordfish Advertising
Swordfish Advertising is a fully integrated pharmaceutical and healthcare agency.
Current Employees Featured
Official Site Inspections
http://www.grindeks.eu Semrush global rank: 9.99 M Semrush visits lastest month: 68
- Host name: ec2-3-66-1-169.eu-central-1.compute.amazonaws.com
- IP address: 3.66.1.169
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Grindeks"
Who we are? - Grindeks
Humanity – we treat people’s health needs with honour and responsibility, we are approachable and ready to help.. Simplicity – we make the complex things simple and do everything we can to make health solutions accessible to everyone.. …See details»
Grindeks - Wikipedia
JSC Grindex (branded as Grindex), or simply Grindeks, is an internationally operating Latvian pharmaceutical company with headquarters in Riga, Latvia. Its portfolio consists of original products, generics, and active pharmaceutical ingredients. It mostly focuses on cardiovascular, central nervous system, anti-cancer, and diabetes medicines. Grindex is the leading pharmaceutical manufa…See details»
In 2020 the Grindeks Group has achieved the historically sharpest ...
Mar 3, 2021 Ph. D. Juris Hmelnickis, the Chairman of the Board of JSC Grindeks describes the last year as a year of significant changes and achievements: “In 2020 we began introducing …See details»
JSC Grindeks - CEEC
The most important export markets of Grindeks are the EU countries, Russia and other CIS countries, the USA, Canada and Japan. Grindeks product portfolio is successfully composed …See details»
Latvian pharmaceutical manufacturing company …
Apr 3, 2024 Grindeks is an international pharmaceutical group that provides a full product lifecycle – research, development, pharmacovigilance, manufacturing, and sales of original products, generic drugs ...See details»
Grindeks - Crunchbase Company Profile & Funding
Organization. Grindeks . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News ... (EU), Europe, Middle East, and Africa (EMEA) Founded Date 1946; ...See details»
Company - Grindeks
Grindeks Group consists of 4 subsidiaries with manufacturing plants in Latvia, Estonia and Slovakia. We do our best to produce high quality active pharmaceutical ingredients and final dosage forms, ensuring our patients and …See details»
Pharmaceutical manufacturer Grindeks opens 28 global …
Apr 9, 2024 Grindeks is actively working on developing new products. It has submitted 30 new products for registration, and more than 100 pharmaceutical formulations are in the development process to increase patient access to …See details»
"Grindeks" Group has reached record high turnover and profit in …
Nov 8, 2021 The "Grindeks" Group consists of JSC "Grindeks" and its companies: JSC "Kalceks" in Latvia, JSC "Tallinn Pharmaceutical Plant" in Estonia, "HBM Pharma" s.r.o. in …See details»
In 2020 the “Grindeks” Group has achieved the historically
Mar 3, 2021 The “Grindeks” Group consists of JSC “Grindeks” and its companies: JSC “Kalceks” in Latvia, JSC “Tallinn Pharmaceutical Plant” in Estonia, “HBM Pharma” s.r.o. in Slovakia, LLC ...See details»
About Grindeks.
The company specializes in the heart and cardiovascular, CNS and anti-cancer medication therapeutic groups. Currently "Grindeks" produces 23 APIs. Products are exported to 87 …See details»
In 2020 the “Grindeks” Group has achieved the historically …
Mar 3, 2021 In 2020 the “Grindeks” Group has strengthened its positions in the global pharmacy market and exported its products to 93 countries for the total amount of 176.1 million euro.See details»
Grindeks Expands Range of Generic Medicines and Activities in ...
Jun 22, 2022 Grindeks believes that it has great potential to expand patients' access to high-quality and effective medicines for treatment of important therapeutic directions – CNS …See details»
History - Grindeks
In 2014, Grindeks opened Quality Control Laboratory , one of the most advanced laboratories in the Baltics. In 2015, Grindeks received the Energy management system certification LVS EN …See details»
“Grindeks” Group strategy has identified four development
Sep 22, 2020 The most important export markets of “Grindeks” are the EU countries, Russia and other CIS countries, the USA, Canada and Japan. Further information: Laila Klavina.See details»
About – Grindeks
Since 2007, Grindeks has recognized the critical role of biotechnology in advancing the pharmaceutical industry, focusing on the specificity and effectiveness of drug therapies. Our …See details»
About us - Grindeks
Today Grindeks Group consists of JSC Grindeks and its subsidiaries. Each one of them is contributing to the growth of the Group and being an integral part of the corporation. At this …See details»
JSC “Grindeks” oxytocin inclusion in World Health - GlobeNewswire
Oct 22, 2019 JSC “Grindeks” informs that World Health Organization (WHO) has included oxytocin solution for injection 10 IU/ml in the List of Prequalified Medicinal Products.See details»
Grindeks Group closes 2021 with record high turnover of EUR …
Feb 2, 2022 The consolidated, provisional financial data of Grindeks Group indicate that the Group has closed 2021 with a record high turnover and profit. In this period, ... Sales of final …See details»